BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1459181)

  • 21. Neuroimmunomodulatory interactions in the genesis and outcome of autoimmune disease.
    Savino W
    Neuroimmunomodulation; 2008; 15(1):5-6. PubMed ID: 18667794
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasticity of neuroendocrine-immune interactions during aging.
    Fabris N
    Acta Neurol (Napoli); 1991 Oct; 13(5):403-9. PubMed ID: 1776528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of neuroendocrine system in the pathogenesis of rheumatic diseases (minireview).
    Imrich R
    Endocr Regul; 2002 Jun; 36(2):95-106. PubMed ID: 12207559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine immune mechanisms in rheumatic diseases. An overview and future implications.
    Masi AT
    Rheum Dis Clin North Am; 2000 Nov; 26(4):1003-17. PubMed ID: 11084956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuropeptides and the immune system].
    Stepień H
    Acta Physiol Pol; 1989; 40 Suppl 34():44-54. PubMed ID: 2488062
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of neuroimmunomodulation in aging.
    De la Fuente M
    Neuroimmunomodulation; 2008; 15(4-6):213-23. PubMed ID: 19047799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoneuroendocrine communication network and homeostasis regulation: the use of hormones and neurohormones as immunotherapy].
    Arteaga M; Chavarría A; Morales Montor J
    Rev Invest Clin; 2002; 54(6):542-9. PubMed ID: 12685222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current concepts of neuroimmunomodulation].
    Aréchiga-Urtuzuástegui H
    Gac Med Mex; 1999; 135(5):489-99. PubMed ID: 10596489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases.
    Bijlsma JW; Cutolo M; Straub RH; Masi AT
    Rheum Dis Clin North Am; 2005 Feb; 31(1):xiii-xvi. PubMed ID: 15639051
    [No Abstract]   [Full Text] [Related]  

  • 30. The vascular endothelial system in the pathogenesis of inflammation and systemic rheumatic diseases: relation to the neuroendocrine system.
    Pitzalis C; Koch A
    Rheum Dis Clin North Am; 2000 Nov; 26(4):765-73. PubMed ID: 11084943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms.
    Cho ZH; Hwang SC; Wong EK; Son YD; Kang CK; Park TS; Bai SJ; Kim YB; Lee YB; Sung KK; Lee BH; Shepp LA; Min KT
    Acta Neurol Scand; 2006 Jun; 113(6):370-7. PubMed ID: 16674603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NHLBI workshop summaries. Neuroimmune interactions in the lung.
    Daniele RP; Barnes PJ; Goetzl EJ; Nadel J; O'Dorisio S; Kiley J; Jacobs T
    Am Rev Respir Dis; 1992 May; 145(5):1230-5. PubMed ID: 1586073
    [No Abstract]   [Full Text] [Related]  

  • 33. The Second International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases.
    Cutolo M
    Isr Med Assoc J; 2002 Apr; 4(4):309-11. PubMed ID: 12001715
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychoneuroendocrinology and psychoneuroimmunology of cancer: Plausible mechanisms worth pursuing?
    Antoni MH
    Brain Behav Immun; 2003 Feb; 17 Suppl 1():S84-91. PubMed ID: 12615191
    [No Abstract]   [Full Text] [Related]  

  • 36. Integrated hormonal-immunological-vascular (H-I-V triad) systems interactions in the rheumatic diseases.
    Masi AT; Feigenbaum SL; Chatterton RT; Cutolo M
    Clin Exp Rheumatol; 1995; 13(2):203-16. PubMed ID: 7656467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond heart rate variability: vagal regulation of allostatic systems.
    Thayer JF; Sternberg E
    Ann N Y Acad Sci; 2006 Nov; 1088():361-72. PubMed ID: 17192580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic options in central nervous system involvement of rheumatologic diseases.
    Gur A
    Curr Pharm Des; 2008; 14(13):1240-1. PubMed ID: 18537648
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuroimmunoendocrine interaction in the pathogenesis of chronic heart failure].
    Poskrebysheva AS; Grinevich VV; Smurova IuV; Shostak NA; Akmaev IG
    Usp Fiziol Nauk; 2003; 34(3):3-20. PubMed ID: 12942758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nutrition in rheumatic diseases].
    Denisov LN
    Revmatologiia (Mosk); 1987; (2):38-44. PubMed ID: 3313637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.